Investidor Profissional Gestao de Recursos Ltda. Purchases New Stake in HCA Healthcare, Inc. (NYSE:HCA)

Investidor Profissional Gestao de Recursos Ltda. bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 784 shares of the company’s stock, valued at approximately $235,000. HCA Healthcare accounts for about 0.1% of Investidor Profissional Gestao de Recursos Ltda.’s holdings, making the stock its 16th largest holding.

Several other large investors have also recently bought and sold shares of HCA. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare during the third quarter worth approximately $39,000. Whipplewood Advisors LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $31,000. Tidemark LLC acquired a new position in shares of HCA Healthcare in the fourth quarter valued at about $36,000. Activest Wealth Management raised its stake in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. increased its holdings in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $332.53 on Friday. The firm has a market cap of $81.87 billion, a PE ratio of 15.14, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The firm’s fifty day moving average is $327.23 and its 200-day moving average is $339.87.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the business earned $5.90 earnings per share. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were paid a dividend of $0.72 per share. The ex-dividend date was Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.87%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 1.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. KeyCorp lowered their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Morgan Stanley decreased their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Royal Bank of Canada reduced their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. Finally, Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.